This suboptimal sensitivity reflects the molecular architecture of the 9p21 locus, where smaller deletions may selectively involve CDKN2A while sparing the adjacent MTAP gene, resulting in melanomas that are p16-negative but retain MTAP expression. Here, CDKN2A is linked to melanoma.